Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Electronic Health Records Speed Chlamydia Treatment

By HospiMedica International staff writers
Posted on 14 Jun 2010
Electronic health records (EHRs) can significantly shorten treatment times for patients diagnosed with the sexually transmitted infection (STI) Chlamydia, according to a new study.

Researchers at Central Middlesex Hospital (London, United Kingdom) examined the medical records of patients treated at a sexual health clinic, either before or after it converted to EHRs. More...
For each of 52 consecutive qualifying patients seen from January to March 2007 (paper case records) and 2009 (EHRs), time intervals were measured between first attendance, first positive result received, first attempted patient contact, and attendance for treatment.

The researchers found that before the clinic adopted EHRs, it took an average of 11.5 days for a patient to receive treatment after a Chlamydia diagnosis, compared with just 3.5 days under the EHR system; and even though results took 2 days longer to arrive in 2009 than in 2007, the time between first attendance and treatment decreased by 9.5 days. In 2007, 38% of patients were treated within 2 weeks of a positive result, compared with 94% in 2009. EHRs were also associated with a greater proportion of patients successfully recalled by telephone, resulting in earlier treatment. The study was published online on May 27, 2010, in the journal Sexually Transmitted Infections.

"Compared with paper notes, EHR decreased the time to recall, by eliminating three time-delaying patient recall processes. The 'time to treat' interval was dramatically reduced after the introduction of EHR,” concluded lead author Gary Brook, M.D., and colleagues. "We suggest that with the increasing use of noninvasive Chlamydia screening methods such as urine sampling, and more effective patient recall, new national standards should be set for the time taken to recall and treat infected patients.”

Chlamydia infection is a common STI in humans caused by the bacterium Chlamydia trachomatis, which is found only in humans. Chlamydia is a major infectious cause of human genital and eye disease, and is one of the most common sexually transmitted infections worldwide; it is estimated that about 1 million individuals in the United States alone are infected with Chlamydia.

Related Links:

Central Middlesex Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.